JSP-191

anti-CD117 monoclonal antibody · Jasper Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JSP-191, covering 2025-07-28 to 2025-07-28. Get the full timeline:

Most recent: Clinical Trial Update: JSP191 Antibody Targeting Conditioning in SCID Patients [Phase 1, Phase 2]